A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)-MedSci.cn

A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)

Gatti-Mays, ME; Palena, C; Gameiro, SR; Donahue, RN; Jochems, C; Steinberg, S; Lipkowitz, S; Zimmer, A; Francis, D; Strauss, J; Sater, HA; Cordes, L; Redman, J; Karzai, F; Bilusic, M; Madan, RA; Gulley, JL; Schlom, J

CANCER RESEARCH, 2020; 80 (4):

科室
- - 订阅+
  - 更多科室
工具
服务